Use of Sentinel Lymph Node Biopsy to Select Patients for Local–Regional Therapy After Neoadjuvant Chemotherapy-Reference-Cited by-同舟云学术

Use of Sentinel Lymph Node Biopsy to Select Patients for Local–Regional Therapy After Neoadjuvant Chemotherapy

Published:2014-01-18 Issue:1 Volume:6 Page:10-16
ISSN:1943-4588
Container-title:Current Breast Cancer Reports
language:en
Short-container-title:Curr Breast Cancer Rep

Author:

Erdahl Lillian M.,Boughey Judy C.

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s12609-013-0135-7.pdf

Reference24 articles.

1. Kakuda JT, Stuntz M, Trivedi V, Klein SR, Vargas HI. Objective assessment of axillary morbidity in breast cancer treatment. Am Surg. 1999;65(10):995–8.

2. Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92(6):1368–77.

3. McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26(32):5213–9.

4. Rutgers EJ, Donker M, Straker ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: Final analysis of the EORTC AMAROS trial (10981/22023). J Clin Oncol. 2013;31(18):(suppl; abstr LBA1001).

5. DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500–15. This combined analysis examined the incidence of unilateral arm lymphedema among breast cancer survivors. The analysis included 72 studies, 30 of which were prospective cohort studies. The conclusion was that approximately one in five breast cancer survivors will experience unilateral arm lymphedema. Risk factors include obesity and extensive lymph node surgery. This information is important for clinicians when counseling patients and assessing the risks and benefits of axillary surgery.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to Have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy;Annals of Surgical Oncology;2023-09-01

2. A Propensity Score Matched Analysis of Superparamagnetic Iron Oxide versus Radioisotope Sentinel Node Biopsy in Breast Cancer Patients after Neoadjuvant Chemotherapy;Cancers;2022-01-28

3. Use of methylene blue dye for lymphatic basin mapping and sentinel lymph node biopsy in breast cancer patients in Enugu, Nigeria;Nigerian Journal of Clinical Practice;2022

4. Radioactivity counters and mono-channel probes;Nuclear Medicine and Molecular Imaging;2022

5. Superparamagnetic Iron Oxide for Identifying Sentinel Lymph Node in Breast Cancer after Neoadjuvant Chemotherapy: Feasibility Study;Journal of Clinical Medicine;2021-07-16